fbpx

Researchers at Yale Have Pinpointed Cells That Are Linked to Macular Degeneration

Researchers have found the cells linked to the leading cause of blindness in elderly.

In the Oct. 25 issue of the journal Nature Communications, Yale researchers reported that glial cells, also called support cells and vasculature cells, which supply blood to the retina as well as cone cells, contribute to macular degeneration.

Genome-wide studies have identified almost three dozen genes that play a role in the disease, but the exact location where they inflict damage had remained unknown until now.

The Yale/Harvard/MIT team used new single-cell sequencing to generate the first comprehensive human retinal atlas. They used data analysis technology to localize their effects to specific cell types associated with the disease.

This new information can help find treatments for macular degeneration in the future. “This study helps pinpoint cell types that can be investigated closely to develop new types of therapeutics,” said co-senior author Brian Hafler, assistant professor of ophthalmology and visual science and of pathology at Yale.

While age is the most significant risk factor for developing age-related macular degeneration (AMD), other risk factors such as heredity, blue eyes, high blood pressure, cardiovascular disease, and smoking have also been identified. AMD accounts for 90% of new cases of legal blindness in Canada.

While current treatments of both the dry and wet form of macular degeneration of injections, photodynamic therapy and vitamin supplements can provide some benefits, there can be continued progressive vision loss even with treatment. There is still a gap for effective treatments for the largely affected population. The identification of these risk cells provides possible points of interest for new therapies to improve and restore vision in AMD patients.

References:

http://.news.yale.edu/2019/10/24/yale-researchers-find-cells-linked-leading-cause-blindness-elderly

https://www.nature.com/articles/s41467-019-12780-8

Featured Posts

Prada Group and EssilorLuxottica logos

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More
EssilorLuxottica

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Read more
Vision Expo new logo

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Read more
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Prada Group and EssilorLuxottica logos

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More
EssilorLuxottica

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Read More
Vision Expo new logo

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

Read More
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Read More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read More
Prada Group and EssilorLuxottica logos

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More
EssilorLuxottica

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Read more
Vision Expo new logo

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Read more
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Prada Group and EssilorLuxottica logos

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More
EssilorLuxottica

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Read more
Vision Expo new logo

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Read more
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more